WolverHeme Happy Hour

By: Bernard Marini Anthony Perissinotti et al.
Listen for free

  • Summary

  • Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.
    Bernard Marini, Anthony Perissinotti, et al.
    Show more Show less
Hygiene & Healthy Living Physical Illness & Disease
Show more Show less
Episodes
  • CSO Encore Video Presentation - SWOG1826 & STARGLO Trials Critically Examined

    CSO Encore Video Presentation - SWOG1826 & STARGLO Trials Critically Examined
    May 5 2025

    This is a special encore video presentation of Anthony and Bernie teaming up with the Common Sense Oncology Journal Club series to discuss the SWOG1826 and STARGLO clinical trials. Tycel Phillips, MD, and Manju Sengar, MD join Anthony and Bernie for a great discussion of the trials and how they should impact practice!


    Join the Common Sense Oncology movement here! https://commonsenseoncology.org/

    Show more Show less
    1 hr and 11 mins
  • Dex and the Cytokine City: Managing CRS with Bispecifics

    Dex and the Cytokine City: Managing CRS with Bispecifics
    Apr 7 2025

    In this episode, Bernie and Anthony are joined by 3 hematology pharmacists - James Davis, PharmD, BCOP; Victoria Nachar, PharmD, BCOP; and Justine Preedit, PharmD, BCOP - to discuss the optimal management of CRS in patients receiving bispecific antibodies!


    Inspired by this recent paper:

    https://www.nature.com/articles/s41408-025-01222-y
    Show more Show less
    1 hr
  • LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML

    LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML
    Mar 11 2025

    In this episode, Bernie and Anthony are joined by Dr. Charlie Foucar and Dr. Anand Patel to review the interesting and controversy-filled saga of gemtuzumab in AML? Should we be using this agent in AML? Tune in to find out!
    Show more Show less
    1 hr and 5 mins
adbl_web_global_use_to_activate_webcro805_stickypopup

What listeners say about WolverHeme Happy Hour

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available